Both osteoclast-activating factor (OAF) and prostaglandins are potent local mediators of bone resorption (1-3). Both of these factors are produced by cells involved in immune responses and are potential mediators of the bone destruction associated with diseases such as rheumatoid arthritis, periodontal disease, and cholesteatoma (4). They may also be produced at the site of metastatic bone lesions. Their interactions at bone resorbing sites therefore may be important in the bone resorption which is associated with a variety of inflammatory and neoplastic diseases. To test if OAF production is dependent on prostaglandins, we have examined the effects of a number of structurally unrelated inhibitors of prostaglandin synthetase on the production of OAF by phytohemagglutinin-(PHA) activated human peripheral blood leukocytes. The production of OAF was inhibited by indomethacin, R020-5720 and flufenamic acid. Inhibition of OAF production by these agents was reversed by adding prostaglandins of the E series back to the leukocyte suspension. These results indicate that prostaglandin synthesis is necessary for OAF production.
injected subcutaneously with 0.05 mCi of 45Ca. The next day the fetuses were removed and the mineralized shafts of the radii and ulnae were dissected free from surrounding subcutaneous soft tissue and the cartilagenous ends. The bones were cultured in control media for 24 h to allow for exchange of loosely complexed 45Ca with stable calcium in the medium. The bones were then cultured with the leukocyte culture supernates for 72 h and bone resorbing activity was assessed as the percent of total radioactivity released from the bones into the culture medium during the period of culture. The leukocyte culture supernates were diluted 1:1 with fresh medium before assay for bone resorbing activity. Bone resorbing activity was also expressed as ratios of~Ca release from the test bones compared with corresponding paired bones cultured in control media. Four bones were used in each test group and differences were assessed using Student's t test.
Results and Discussion
Each of the structurally unrelated inhibitors of prostaglandin synthetase inhibited the production of OAF by leukocytes at 10 -5 M (Table I ). In the same experiments, these drugs did not inhibit protein or DNA synthesis by the leukocytes as measured by the incorporation of all-amino acids of [aH]thymidine into the cells. The inhibitory effects of these drugs on OAF production were obtained with concentrations as low as 10 -7 M (data not shown). Although each of these drugs inhibited OAF production, they had no effect on the biological activity due to OAF when they were added to OAF containing media in concentrations of 10 -5 M. OAF production was restored by adding prostaglandins of the E series together with indomethacin to the leukocytes before the leukocytes were activated with PHA (Table II) . Similar effects were seen with both prostaglandin-E1 and prostaglandin-E2. However, prostaglandin-Fl~ and -F2, had no significant effect on restoration of OAF activity. Prostaglandins were The prostaglandins and indo were added to the leukocytes 2 h before the addition of PHA. The leukocytes (lk) were then cultured for 48 h. The Ik culture supernates were assayed for bone resorping activity before and after diafihration to remove the prostaglandins.
Values are means ± SEM for four pairs of bone cultures. * Significantly greater than 1.0, P < 0.05.
removed from the leukocyte-conditioned media before assay for bone resorbing activity by diafiltration (uhrafiltration with continuous replacement of the filtered volume with 10 vol of fresh media) across an Amicon UM2 membrane (Amicon Corp., Lexington, Mass.), which has a nominal tool wt cut-off of 1,000 daltons. Restoration of OAF production indicates that prostaglandin synthesis by the leukocyte cultures is necessary for OAF to be produced.
A number of studies have indicated that prostaglandins may be endogenous modulators of cell-mediated immune responses and lymphokine production. Prostaglandins have been shown to both stimulate and inhibit the production of different lymphokines. Most of the described effects of prostaglandins on lymphokine production have been inhibitory. Large concentrations of prostaglandins have been shown to inhibit macrophage migration inhibition factor production by guinea pigs (10, 1 1) , mitogen-induced stimulation of murine lymphocytes (12) and human leukocyte inhibitory factor production (13). Goodwin et al. have suggested that prostaglandin production by glass-adherent cells inhibits T-cell mitogenesis (14) . In contrast, prostaglandins of the E series appear to be necessary for the production of a factor by activated leukocytes which increases vascular permeability (15) . Now we have shown that prostaglandins are also necessary for the production of another lymphokine, OAF.
The cell source of prostaglandins necessary for OAF production in our experiments is likely to be the monocyte. The monocyte is the principal PGE-producing cell in human peripheral blood (16) . The presence of monocytes in the leukocyte population is necessary for OAF production, but not for leukocyte activation (17) . Nonadherent lymphocytes devoid of monocytes which are incubated with PHA synthesize DNA and protein, but do not release OAF (17) . T cells alone require the presence of monocytes in order to release OAF after activation with PHA (18) . Our data reported here suggests that the synergy between the monocyte and the lymphocyte in the production of OAF may be mediated by prostaglandins.
Regardless of the mechanism of the interaction between prostaglandins and leukocytes in OAF production, our data indicate that prostaglandins are necessary for the production of OAF by stimulated leukocytes, but they are not essential for leukocyte activation as assessed by DNA or protein synthesis. These data also clearly show that responses to indomethacin and related drugs do not prove a prostaglandinmediated mechanism of bone resorption in animals or in patients with hypercalcemia.
Summary
The production of osteoclast-activating factor (OAF) by normal human peripheral blood leukocytes stimulated by phytohemagglutinin was inhibited by a series of structurally unrelated inhibitors of prostaglandin synthetase. Inhibition of OAF production by these agents was reversed by adding prostaglandins of the E series back to the leukocyte suspension. These results indicate that prostaglandin synthesis is necessary for OAF production.
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